☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Metastatic
Junshi Reports NMPA's Acceptance of sNDA for Toripalimab + CT as 1L Treatment for Advanced or Metastatic Esophageal Squamous Cell...
July 30, 2021
BMS Presents Results of Opdivo (nivolumab) + CT or Yervoy (ipilimumab) in P-III CheckMate -648 Trial for Unresectable Advanced or...
June 4, 2021
The US FDA Grants Priority Review to Takeda's Mobocertinib (TAK-788) for EGFR Exon20 Insertion+ Metastatic Non-Small Cell Lung Can...
April 28, 2021
Astellas and Seagen Report the US FDA's Acceptance of Two sBLA for Padcev (enfortumab vedotin) in Locally Advanced or Metastatic U...
April 20, 2021
Roche's Tecentriq Receives CHMP's Positive Opinion for 1L Treatment for Metastatic Non-Small Cell Lung Cancer
March 29, 2021
Astellas and Seagen Report EMA's Acceptance of MAA for Enfortumab Vedotin to Treat Locally Advanced or Metastatic Urothelial Cance...
March 26, 2021
Load more...
Back to Home
Modal title
×
Modal body text goes here.